Search
Search Results
##search.searchResults.foundPlural##
-
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277948PDF: 1914HTML: 3916 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3568PDF: 1660HTML: 4096 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3903PDF: 1804HTML: 2784 -
TYROSINE KINASE INHIBITORS AND INTERFERON
3057PDF: 1531HTML: 3106Cover Letter: 272 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2380PDF: 1700HTML: 747 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4498PDF: 2057HTML: 5570Table 1: 300 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4235PDF: 1651HTML: 9332Untitled: 345Untitled: 232Untitled: 218Untitled: 230Untitled: 233Untitled: 393 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3374PDF: 1443HTML: 4169 -
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
3042PDF: 763HTML: 1975figure 1: 234figure 2: 224 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1644PDF: 1353HTML: 545 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5215PDF: 3023HTML: 2383 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
3025PDF: 1213HTML: 3090 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3478PDF: 1646HTML: 567
1 - 29 of 29 items







